LUNG METASTASIS: EMERGING TARGETS AND OPPORTUNITIES FOR THERAPEUTIC INTERVENTION

被引:0
|
作者
Hiscox, Stephen [1 ]
机构
[1] Cardiff Univ, Sch Pharm & Pharmaceut Sci, Cardiff CF10 3AX, S Glam, Wales
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
SBO5B05
引用
收藏
页码:4318 / 4318
页数:1
相关论文
共 50 条
  • [41] Pleural mesothelioma: a snapshot of emerging drug targets and opportunities for non-surgical therapeutic advancement
    Assie, Jean-Baptiste
    Jean, Didier
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2023, 27 (11) : 1059 - 1069
  • [42] Bone metastasis: mechanisms and therapeutic opportunities
    Suva, Larry J.
    Washam, Charity
    Nicholas, Richard W.
    Griffin, Robert J.
    NATURE REVIEWS ENDOCRINOLOGY, 2011, 7 (04) : 208 - 218
  • [43] Bone metastasis: mechanisms and therapeutic opportunities
    Larry J. Suva
    Charity Washam
    Richard W. Nicholas
    Robert J. Griffin
    Nature Reviews Endocrinology, 2011, 7 : 208 - 218
  • [44] Emerging therapeutic targets - Molecular targets for weight control
    Gurwitz, D
    DRUG DISCOVERY TODAY, 1998, 3 (09) : 426 - 426
  • [45] Epigenetic markers and therapeutic targets for metastasis
    Kravitz, Carolyn J.
    Yan, Qin
    Nguyen, Don X.
    CANCER AND METASTASIS REVIEWS, 2023, 42 (02) : 427 - 443
  • [46] Novel therapeutic targets for cancer metastasis
    Stoletov, Konstantin
    Beatty, Perrin H.
    Lewis, John D.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (02) : 97 - 109
  • [47] Epigenetic markers and therapeutic targets for metastasis
    Carolyn J. Kravitz
    Qin Yan
    Don X. Nguyen
    Cancer and Metastasis Reviews, 2023, 42 : 427 - 443
  • [48] Emerging therapeutic opportunities for skeletal restoration
    Masanobu Kawai
    Ulrike I. Mödder
    Sundeep Khosla
    Clifford J. Rosen
    Nature Reviews Drug Discovery, 2011, 10 : 141 - 156
  • [49] Emerging therapeutic opportunities for integrin inhibitors
    Slack, R. J.
    Macdonald, S. J. F.
    Roper, J. A.
    Jenkins, R. G.
    Hatley, R. J. D.
    NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (01) : 60 - 78
  • [50] Emerging therapeutic opportunities for integrin inhibitors
    R. J. Slack
    S. J. F. Macdonald
    J. A. Roper
    R. G. Jenkins
    R. J. D. Hatley
    Nature Reviews Drug Discovery, 2022, 21 : 60 - 78